159 related articles for article (PubMed ID: 36854895)
1. β3-adrenergic receptor on tumor-infiltrating lymphocytes sustains IFN-γ-dependent PD-L1 expression and impairs anti-tumor immunity in neuroblastoma.
Bruno G; Nastasi N; Subbiani A; Boaretto A; Ciullini Mannurita S; Mattei G; Nardini P; Della Bella C; Magi A; Pini A; De Marco E; Tondo A; Favre C; Calvani M
Cancer Gene Ther; 2023 Jun; 30(6):890-904. PubMed ID: 36854895
[TBL] [Abstract][Full Text] [Related]
2. Targeting β3-adrenergic receptor signaling inhibits neuroblastoma cell growth via suppressing the mTOR pathway.
Deng J; Jiang P; Yang T; Huang M; Qi W; Zhou T; Yang Z; Zou Y; Gao G; Yang X
Biochem Biophys Res Commun; 2019 Jun; 514(1):295-300. PubMed ID: 31030945
[TBL] [Abstract][Full Text] [Related]
3. β3-adrenoreceptor blockade reduces tumor growth and increases neuronal differentiation in neuroblastoma via SK2/S1P
Bruno G; Cencetti F; Pini A; Tondo A; Cuzzubbo D; Fontani F; Strinna V; Buccoliero AM; Casazza G; Donati C; Filippi L; Bruni P; Favre C; Calvani M
Oncogene; 2020 Jan; 39(2):368-384. PubMed ID: 31477835
[TBL] [Abstract][Full Text] [Related]
4. The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy.
Qian J; Wang C; Wang B; Yang J; Wang Y; Luo F; Xu J; Zhao C; Liu R; Chu Y
J Neuroinflammation; 2018 Oct; 15(1):290. PubMed ID: 30333036
[TBL] [Abstract][Full Text] [Related]
5. Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8
Li YM; Yu JM; Liu ZY; Yang HJ; Tang J; Chen ZN
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627272
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease.
Srinivasan P; Wu X; Basu M; Rossi C; Sandler AD
PLoS Med; 2018 Jan; 15(1):e1002497. PubMed ID: 29377881
[TBL] [Abstract][Full Text] [Related]
7. CD69 on Tumor-Infiltrating Cells Correlates With Neuroblastoma Suppression by Simultaneous PD-1 and PD-L1 Blockade.
Inoue S; Takeuchi Y; Horiuchi Y; Murakami T; Odaka A
J Surg Res; 2023 Sep; 289():190-201. PubMed ID: 37141702
[TBL] [Abstract][Full Text] [Related]
8. Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer.
Falcinelli M; Al-Hity G; Baron S; Mampay M; Allen MC; Samuels M; Jones W; Cilibrasi C; Flaherty RL; Giamas G; Thaker PH; Flint MS
Brain Behav Immun; 2023 May; 110():1-12. PubMed ID: 36796704
[TBL] [Abstract][Full Text] [Related]
9. A Systematic Review of the Tumor-Infiltrating CD8
Shadbad MA; Asadzadeh Z; Hosseinkhani N; Derakhshani A; Alizadeh N; Brunetti O; Silvestris N; Baradaran B
Front Immunol; 2021; 12():734956. PubMed ID: 34603316
[TBL] [Abstract][Full Text] [Related]
10. Establishment of humanized tumor microenvironment mouse models based on the injection of peripheral blood mononuclear cells and IFN-γ to evaluate the efficacy of PD-L1/PD-1-targeted immunotherapy.
Lin X; Zeng T; Lin J; Zhang Q; Cheng H; Fang S; Lin S; Chen Y; Xu Y; Lin J
Cancer Biol Ther; 2020; 21(2):130-138. PubMed ID: 31690181
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians.
Bie F; Tian H; Sun N; Zang R; Zhang M; Song P; Liu L; Peng Y; Bai G; Zhou B; Gao S
Clin Epigenetics; 2021 Dec; 13(1):229. PubMed ID: 34933667
[TBL] [Abstract][Full Text] [Related]
12. β3-Adrenoreceptor Blockade Induces Stem Cells Differentiation in Melanoma Microenvironment.
Calvani M; Bruno G; Dabraio A; Subbiani A; Bianchini F; Fontani F; Casazza G; Vignoli M; De Logu F; Frenos S; Filippi L; Favre C
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093135
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of neutrophils-to-lymphocytes ratio (NLR), PD-L1 expression, and tumor immune microenvironment in laryngeal cancer.
Franz L; Alessandrini L; Fasanaro E; Gaudioso P; Carli A; Nicolai P; Marioni G
Ann Diagn Pathol; 2021 Feb; 50():151657. PubMed ID: 33189034
[TBL] [Abstract][Full Text] [Related]
14. Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma.
Melaiu O; Chierici M; Lucarini V; Jurman G; Conti LA; De Vito R; Boldrini R; Cifaldi L; Castellano A; Furlanello C; Barnaba V; Locatelli F; Fruci D
Nat Commun; 2020 Nov; 11(1):5992. PubMed ID: 33239635
[TBL] [Abstract][Full Text] [Related]
15. IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling.
Gao Y; Yang J; Cai Y; Fu S; Zhang N; Fu X; Li L
Int J Cancer; 2018 Aug; 143(4):931-943. PubMed ID: 29516506
[TBL] [Abstract][Full Text] [Related]
16. Direct AKT activation in tumor-infiltrating lymphocytes markedly increases interferon-γ (IFN-γ) for the regression of tumors resistant to PD-1 checkpoint blockade.
Santinon F; Ezzahra BF; Bachais M; Sarabia Pacis A; Rudd CE
Sci Rep; 2022 Nov; 12(1):18509. PubMed ID: 36323740
[TBL] [Abstract][Full Text] [Related]
17. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.
Hu C; Zhao L; Liu W; Fan S; Liu J; Liu Y; Liu X; Shu L; Liu X; Liu P; Deng C; Qiu Z; Chen C; Jiang Y; Liang Q; Yang L; Shao Y; He Q; Yu D; Zeng Y; Li Y; Pan Y; Zhang S; Shi S; Peng Y; Wu F
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887263
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.
Suriyo T; Fuangthong M; Artpradit C; Ungtrakul T; Sricharunrat T; Taha F; Satayavivad J
Eur J Pharmacol; 2021 Apr; 897():173960. PubMed ID: 33617828
[TBL] [Abstract][Full Text] [Related]
19. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC
Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer.
Teramoto K; Igarashi T; Kataoka Y; Ishida M; Hanaoka J; Sumimoto H; Daigo Y
Lung Cancer; 2019 Nov; 137():56-63. PubMed ID: 31546072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
